Pfizer Inc (PFE)

$26.80 -0.51 (-1.87%)
Market Cap 156.49B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.53
Forward PE 9.24
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 34,684,527
Avg Vol 38,171,973
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 54%
Beta 0.43
Analysts Sell
Price Target $29.05

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
sam92
sam92 Apr. 22 at 9:01 PM
$PFE Pfizer (PFE) declares $0.43/share quarterly dividend, in line with previous. Forward yield 6.42% Payable June 12; for shareholders of record May 8; ex-div May 8.
0 · Reply
jdubh22a
jdubh22a Apr. 22 at 8:51 PM
$PFE damn is pfe on stocktwits ? I got the email minutes after i posted 350th consecutive dividend
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Apr. 22 at 8:49 PM
$PFE - Purrfect https://investors.pfizer.com/Investors/news-events/News/news-details/2026/Pfizer-Declares-Second-Quarter-2026-Dividend/default.aspx
0 · Reply
jdubh22a
jdubh22a Apr. 22 at 8:39 PM
$PFE when is ex div date , usually i have no prob finding right now im not having luck
0 · Reply
snakeii
snakeii Apr. 22 at 8:33 PM
$PFE Crushed me today, I was in Puts Never Mind, Will make it back.
0 · Reply
swingFTW
swingFTW Apr. 22 at 8:08 PM
$PFE looking a bit like an oversold move today, so bought back my May 15 30Cs at close and sold May 1 26Ps
1 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 22 at 7:59 PM
$PFE and a sell off into close, fuck this stock 🥰
1 · Reply
FillSniper42
FillSniper42 Apr. 22 at 7:57 PM
IQST is bottomed out with an upcomign product launch and severely undervalued - No dilution and bottomed out - $300M+ yearly revenue with 1B+ forecasted for 2027 - $18 Price Tartget by litchfield (currently trading under $2) $SNAP $MRVL $NFLX $SIDU $PFE ww
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 22 at 7:37 PM
$PFE half daily volume
0 · Reply
1hawk
1hawk Apr. 22 at 7:28 PM
$PFE love it. Literally my checking account stock that pays me 6 percent plus a 5 year 100 percent stock price increase 🤞 no brainer if you dont want to gamble NFA
1 · Reply
Latest News on PFE
Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 22, 2026, 5:18 AM EDT - 12 hours ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 21, 2026, 11:51 AM EDT - 1 day ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Apr 20, 2026, 3:05 PM EDT - 2 days ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Apr 20, 2026, 6:45 AM EDT - 2 days ago

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 6 days ago

The Big 3: PFE, V, SYF

SYF V

Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 11 days ago

Big Pharma Is Turning to China for the Newest Drug Ideas

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Apr 9, 2026, 10:00 AM EDT - 13 days ago

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Why Is Pfizer Stock Dropping Tuesday?

Apr 7, 2026, 1:54 PM EDT - 15 days ago

Why Is Pfizer Stock Dropping Tuesday?

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Apr 2, 2026, 11:14 AM EDT - 20 days ago

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

NVO LLY

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Apr 1, 2026, 11:39 AM EDT - 21 days ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

BNTX

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Apr 1, 2026, 10:13 AM EDT - 21 days ago

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

Mar 30, 2026, 10:44 AM EDT - 23 days ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 4 weeks ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

Mar 23, 2026, 10:35 AM EDT - 4 weeks ago

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 4 weeks ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 4 weeks ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 4 weeks ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 4 weeks ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 4 weeks ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 4 weeks ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 4 weeks ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 4 weeks ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 5 weeks ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 5 weeks ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 5 weeks ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 6 weeks ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 6 weeks ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 6 weeks ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 6 weeks ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 7 weeks ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

Mar 3, 2026, 8:10 AM EST - 7 weeks ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

PRGO XRAY

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 7 weeks ago

Pfizer CEO flags issues with FDA's vaccine leadership

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 7 weeks ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 2 months ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 2 months ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 2 months ago

Pfizer in diabetes drug deal with Sciwind Biosciences

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 2 months ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK MRNA

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Feb 23, 2026, 10:00 AM EST - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 2 months ago

Is There 25% Downside For Pfizer Stock?

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 2 months ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 2 months ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 2 months ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 2 months ago

Is Pfizer Stock Now A Value Trap?

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Feb 10, 2026, 3:20 PM EST - 2 months ago

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Feb 6, 2026, 2:55 PM EST - 2 months ago

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Feb 6, 2026, 6:45 AM EST - 2 months ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Feb 5, 2026, 7:09 PM EST - 2 months ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

Feb 3, 2026, 1:27 PM EST - 2 months ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR LLY NVO VKTX

Silver Surges Over 15%; Pfizer Earnings Top Views

Feb 3, 2026, 12:00 PM EST - 2 months ago

Silver Surges Over 15%; Pfizer Earnings Top Views

sam92
sam92 Apr. 22 at 9:01 PM
$PFE Pfizer (PFE) declares $0.43/share quarterly dividend, in line with previous. Forward yield 6.42% Payable June 12; for shareholders of record May 8; ex-div May 8.
0 · Reply
jdubh22a
jdubh22a Apr. 22 at 8:51 PM
$PFE damn is pfe on stocktwits ? I got the email minutes after i posted 350th consecutive dividend
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Apr. 22 at 8:49 PM
$PFE - Purrfect https://investors.pfizer.com/Investors/news-events/News/news-details/2026/Pfizer-Declares-Second-Quarter-2026-Dividend/default.aspx
0 · Reply
jdubh22a
jdubh22a Apr. 22 at 8:39 PM
$PFE when is ex div date , usually i have no prob finding right now im not having luck
0 · Reply
snakeii
snakeii Apr. 22 at 8:33 PM
$PFE Crushed me today, I was in Puts Never Mind, Will make it back.
0 · Reply
swingFTW
swingFTW Apr. 22 at 8:08 PM
$PFE looking a bit like an oversold move today, so bought back my May 15 30Cs at close and sold May 1 26Ps
1 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 22 at 7:59 PM
$PFE and a sell off into close, fuck this stock 🥰
1 · Reply
FillSniper42
FillSniper42 Apr. 22 at 7:57 PM
IQST is bottomed out with an upcomign product launch and severely undervalued - No dilution and bottomed out - $300M+ yearly revenue with 1B+ forecasted for 2027 - $18 Price Tartget by litchfield (currently trading under $2) $SNAP $MRVL $NFLX $SIDU $PFE ww
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 22 at 7:37 PM
$PFE half daily volume
0 · Reply
1hawk
1hawk Apr. 22 at 7:28 PM
$PFE love it. Literally my checking account stock that pays me 6 percent plus a 5 year 100 percent stock price increase 🤞 no brainer if you dont want to gamble NFA
1 · Reply
DragonAlgo
DragonAlgo Apr. 22 at 7:09 PM
🐉 $PFE CALL — DragonAlgo® Signal Contract: PFE CALL Expiry: 2026-04-24 | Strike: $26.50 | Type: CALL Option Plan (premium): Entry: $0.48 Stop: $0.35 TP1: $0.63 TP2: $0.82 TP3: $1.16 🔗 https://dragonalgo.com
0 · Reply
SaintKitty
SaintKitty Apr. 22 at 6:58 PM
$PFE $SPY https://www.reuters.com/legal/litigation/pfizer-glp-1-weight-loss-drug-available-pre-order-china-2026-04-22/
0 · Reply
SaintKitty
SaintKitty Apr. 22 at 6:57 PM
$PFE shouldn't it be up on this? https://www.reuters.com/legal/litigation/pfizer-glp-1-weight-loss-drug-available-pre-order-china-2026-04-22/
1 · Reply
Tiger65
Tiger65 Apr. 22 at 6:51 PM
$PFE a jump to 30 US$ would be welcome. Maybe a manipulation today to buy cheap. 
1 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Apr. 22 at 6:49 PM
$SLS $PFE $LLY $ABBV Smarter than you, know this Enhanced Dosing Discovery by Harvard Professor, Dr. Amrein Completely deRisks 009. Dr. Amrein's data Confirms 009 Future Data - will Be Better - than Prior P2B SLS009 data published at ASH, - which was better than data that got bought for $4.9B. $SLS $0.888B 600% ROI on the Table - FREE MONEY
0 · Reply
Willieberich
Willieberich Apr. 22 at 6:41 PM
$PFE 4500 shares added today .will buy more down here ...
0 · Reply
G101SPM
G101SPM Apr. 22 at 6:39 PM
#SHOWTIME Pfizer Inc. Annual General Meeting (April 23) Scheduled to appear: $PFE Johnson & Johnson Annual General Meeting (April 23) Scheduled to appear: $JNJ HCA Healthcare Inc Annual General Meeting (April 23) Scheduled to appear:$ HCA
0 · Reply
Tiger65
Tiger65 Apr. 22 at 6:14 PM
$PFE tomorrow Annual Meeting 2026 at 09:00 ET - outlook pipeline, R & D, possible catalysts incoming.
1 · Reply
scotttrader213
scotttrader213 Apr. 22 at 5:57 PM
$PFE adding more at this level.
0 · Reply
NomadiCapital
NomadiCapital Apr. 22 at 5:27 PM
$PFE I know PFE goes higher but I’ll write options on it till it does. Free money. Still riding weekly 20 ema Stochastics ALMOST oversold Piercing 6Hr bands which many times is the bottoming area before it bounces Also monthly hammer in same spot. I don’t see it dropping more than low $26’s.
0 · Reply
pasuny
pasuny Apr. 22 at 5:23 PM
$PFE Disgusting pharmaceutical company with full of scams. It's like a pho phuc lai from Pho king which is made by Minh Phuc.
1 · Reply
MrPeanutEsquire
MrPeanutEsquire Apr. 22 at 5:00 PM
$PFE When you own a high flyer like Pfizer you have to expect occasional days like this
2 · Reply